Diabetic foot ulcers and vascular insufficiency

Our population has changed, but our methods have not

David G Armstrong, Kelman Cohen, Stephane Courric, Manish Bharara, William Marston

Research output: Contribution to journalArticle

63 Citations (Scopus)

Abstract

Diabetic foot complications are increasing in prevalence worldwide. Care and attention to these complications have improved greatly. Many advanced therapies are now being investigated or taken through final stages of clinical studies worldwide. However, the data upon which assumptions regarding morbidity, healing, and mortality have been based are grossly outdated. The purpose of this brief article is to report on current data regarding neuropathic and neuroischemic wounds and to propose that the latter category of advanced-stage diabetic foot wound may now be emerging as the most commonly encountered lesion in the developed world. Unfortunately, it is still systematically excluded from most clinical study criteria. Additionally, just as in the care of cancer, we call for therapy of these advanced-stage diabetic foot ulcers to be managed in similarly interdisciplinary centers where patients may have access to potentially beneficial clinical trials.

Original languageEnglish (US)
Pages (from-to)1591-1595
Number of pages5
JournalJournal of diabetes science and technology
Volume5
Issue number6
DOIs
StatePublished - 2011

Fingerprint

Diabetic Foot
Blood Vessels
Population
Wounds and Injuries
Diabetes Complications
Clinical Trials
Morbidity
Mortality
Therapeutics
Neoplasms
Clinical Studies

Keywords

  • Amputation
  • Diabetic foot ulcers
  • Infection
  • Ischemia
  • Wound healing

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Internal Medicine
  • Bioengineering
  • Biomedical Engineering

Cite this

Diabetic foot ulcers and vascular insufficiency : Our population has changed, but our methods have not. / Armstrong, David G; Cohen, Kelman; Courric, Stephane; Bharara, Manish; Marston, William.

In: Journal of diabetes science and technology, Vol. 5, No. 6, 2011, p. 1591-1595.

Research output: Contribution to journalArticle

@article{ce6de4919b4946e39ba20347f2714f57,
title = "Diabetic foot ulcers and vascular insufficiency: Our population has changed, but our methods have not",
abstract = "Diabetic foot complications are increasing in prevalence worldwide. Care and attention to these complications have improved greatly. Many advanced therapies are now being investigated or taken through final stages of clinical studies worldwide. However, the data upon which assumptions regarding morbidity, healing, and mortality have been based are grossly outdated. The purpose of this brief article is to report on current data regarding neuropathic and neuroischemic wounds and to propose that the latter category of advanced-stage diabetic foot wound may now be emerging as the most commonly encountered lesion in the developed world. Unfortunately, it is still systematically excluded from most clinical study criteria. Additionally, just as in the care of cancer, we call for therapy of these advanced-stage diabetic foot ulcers to be managed in similarly interdisciplinary centers where patients may have access to potentially beneficial clinical trials.",
keywords = "Amputation, Diabetic foot ulcers, Infection, Ischemia, Wound healing",
author = "Armstrong, {David G} and Kelman Cohen and Stephane Courric and Manish Bharara and William Marston",
year = "2011",
doi = "10.1177/193229681100500636",
language = "English (US)",
volume = "5",
pages = "1591--1595",
journal = "Journal of diabetes science and technology",
issn = "1932-2968",
publisher = "Diabetes Technology Society",
number = "6",

}

TY - JOUR

T1 - Diabetic foot ulcers and vascular insufficiency

T2 - Our population has changed, but our methods have not

AU - Armstrong, David G

AU - Cohen, Kelman

AU - Courric, Stephane

AU - Bharara, Manish

AU - Marston, William

PY - 2011

Y1 - 2011

N2 - Diabetic foot complications are increasing in prevalence worldwide. Care and attention to these complications have improved greatly. Many advanced therapies are now being investigated or taken through final stages of clinical studies worldwide. However, the data upon which assumptions regarding morbidity, healing, and mortality have been based are grossly outdated. The purpose of this brief article is to report on current data regarding neuropathic and neuroischemic wounds and to propose that the latter category of advanced-stage diabetic foot wound may now be emerging as the most commonly encountered lesion in the developed world. Unfortunately, it is still systematically excluded from most clinical study criteria. Additionally, just as in the care of cancer, we call for therapy of these advanced-stage diabetic foot ulcers to be managed in similarly interdisciplinary centers where patients may have access to potentially beneficial clinical trials.

AB - Diabetic foot complications are increasing in prevalence worldwide. Care and attention to these complications have improved greatly. Many advanced therapies are now being investigated or taken through final stages of clinical studies worldwide. However, the data upon which assumptions regarding morbidity, healing, and mortality have been based are grossly outdated. The purpose of this brief article is to report on current data regarding neuropathic and neuroischemic wounds and to propose that the latter category of advanced-stage diabetic foot wound may now be emerging as the most commonly encountered lesion in the developed world. Unfortunately, it is still systematically excluded from most clinical study criteria. Additionally, just as in the care of cancer, we call for therapy of these advanced-stage diabetic foot ulcers to be managed in similarly interdisciplinary centers where patients may have access to potentially beneficial clinical trials.

KW - Amputation

KW - Diabetic foot ulcers

KW - Infection

KW - Ischemia

KW - Wound healing

UR - http://www.scopus.com/inward/record.url?scp=84855408201&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84855408201&partnerID=8YFLogxK

U2 - 10.1177/193229681100500636

DO - 10.1177/193229681100500636

M3 - Article

VL - 5

SP - 1591

EP - 1595

JO - Journal of diabetes science and technology

JF - Journal of diabetes science and technology

SN - 1932-2968

IS - 6

ER -